The last time a U.S. president reshaped the financial architecture of the modern world with a single unilateral act, the announcement came on a Sunday night in August 1971. Richard Nixon walked into the Oval Office, addressed the nation calmly, and dismantled the cornerstone of the postwar monetary order. Markets were closed. Allies were not consulted. The world woke up Monday to a different dollar.
More than half a century later, the United States is living through another period of executive financial ambition on a scale that has few modern precedents. Tariffs imposed, struck down, and reimposed by presidential proclamation. The Federal Reserve’s regulatory independence being pulled, incrementally, toward the White House. Drug prices restructured through executive action rather than legislation. Gold reserves at Fort Knox suddenly a subject of public curiosity. And an administration openly searching for legal authorities to keep its trade architecture standing after the Supreme Court removed its main pillar.
This report examines the key financial and trade executive actions of 2026, what they attempt, where they have already failed in court, and how the Nixon Shock of 1971 casts a direct historical shadow over what is happening right now.
Executive Summary
On February 20, 2026, in Learning Resources Inc. v. Trump, the Supreme Court ruled that the International Emergency Economic Powers Act (IEEPA) does not authorize the president to impose sweeping, open-ended tariffs, striking down the legal foundation for a central pillar of the administration’s trade strategy. Within hours, the administration pivoted to a World War II-era statute most Americans have never heard of. That pivot was then challenged – and partially invalidated again – by a federal trade court just days ago. Meanwhile, the administration has restructured drug pricing through executive order, tightened White House oversight of financial regulators, and raised questions about the valuation of U.S. gold reserves for the first time since 1973.
According to the Federal Register, Donald J. Trump has signed 258 executive orders between 2025 and 2026 combined – a pace of executive activity that has rewritten not just policy, but the constitutional relationship between the presidency and the power of the purse.
The Nixon Shock: Historical Blueprint or Cautionary Tale?
Before dissecting the actions of 2026, the Nixon Shock of 1971 requires context. It is not merely historical color. It is the direct legal and monetary ancestor of the current trade dispute.
The Nixon Shock was a series of economic measures, including wage and price freezes, surcharges on imports, and the unilateral cancellation of the direct international convertibility of the United States dollar to gold, taken by President Richard Nixon on August 15, 1971, in response to increasing inflation and threats of a currency crisis.
Nixon went on national television and announced that he had “directed Secretary Connally to suspend temporarily the convertibility of the dollar into gold.” With those words, the United States abandoned the Bretton Woods system that had anchored global currencies to gold through the U.S. dollar since the end of World War II.
The financial pressure behind that decision was severe. Between 1958 and 1971, U.S. gold reserves plummeted from $25 billion to $10 billion. In May 1971 alone, $5 billion in gold left the United States. Nixon’s “temporary” suspension became permanent. By 1973, a floating exchange rate regime had replaced the Bretton Woods system for other global currencies.
The Nixon Shock has been widely considered a political success but an economic failure, contributing to the 1973 – 1975 recession, the stagflation of the 1970s, and the instability of floating currencies. That last legacy matters enormously for understanding 2026. The tools Congress gave the president after 1971 – including Section 122 of the Trade Act of 1974 – were designed specifically for the post-Bretton Woods monetary world. Whether those tools still legally apply in the floating-currency era of today is, quite literally, what federal courts are now deciding.
Nixon’s three-part shock – ending dollar-gold convertibility, instituting temporary wage and price controls, and imposing a 10 percent surcharge on imports – was initially greeted enthusiastically by investors. But just as Nixon sought a way to circumvent market forces, Trump is trying to buck, by executive fiat, the economic logic that determines trade flows.
The IEEPA Tariffs: A Historic Overreach, and Its Undoing
When Trump returned to the White House in January 2025, his administration moved quickly to deploy the International Emergency Economic Powers Act as its primary tariff instrument. The IEEPA, passed in 1977, gives the president broad authority to regulate economic transactions during a declared national emergency involving an unusual foreign threat. Trump declared national emergencies over two foreign threats: the influx of illegal drugs from Canada, Mexico, and China, and persistent trade deficits affecting U.S. manufacturing and supply chains. Invoking IEEPA, he imposed tariffs of 25% on most Canadian and Mexican imports, 10% on most Chinese imports for drug trafficking concerns, and at least 10% on all imports for trade deficit concerns, with higher rates for dozens of nations.
The legality of that strategy was challenged almost immediately. The U.S. Court of International Trade ruled in May 2025 that the president does not have the authority to use IEEPA to set tariffs, and permanently enjoined the government from enforcing them. That ruling was upheld on appeal by the en banc Federal Circuit Appeals Court in August 2025.
In a 6-3 decision, the Supreme Court ultimately struck down the centerpiece of President Trump’s economic agenda. The majority opinion, written by Chief Justice John Roberts and joined by Justices Sotomayor, Kagan, Gorsuch, Barrett, and Brown Jackson, stated that IEEPA does not give the president the power to set tariffs.
The fiscal scale of the ruling was staggering. The Tax Foundation estimates IEEPA tariffs raised more than $160 billion for the federal government through February 20, 2026, and would have raised $1.4 trillion from 2026 through 2035. The ruling shielded U.S. taxpayers from that major tax increase and erased nearly three-fourths of the new tariff revenue the Trump administration hoped to raise. The question of refunds for businesses that had already paid those duties remains unresolved.
Section 122: The Nixon-Era Statute Nobody Had Ever Used Before
The administration had prepared for this outcome. Within hours of the Supreme Court ruling, Trump’s IEEPA tariffs were struck down and the White House reimposed tariffs under Section 122 of the Trade Act of 1974.
Section 122 had never before been invoked, representing a historic moment for presidential economic policy. Understanding why requires returning to 1971. The Trade Act of 1974 was created during a period of economic uncertainty. It was largely meant to protect the U.S. currency and came after a period of large U.S. trade deficits. Section 122 was enacted after President Nixon declared a goal of improving the U.S. balance of payments. Congress approved the Act to provide the president with emergency authority to prevent “depreciation of the dollar in foreign exchange markets” and to correct “an international balance-of-payments disequilibrium.”
The statute’s constraints are tight. Congress established Section 122 to provide legal authority for imposing tariffs in response to a balance-of-payments crisis. It authorizes the president to impose tariffs of up to 15% for a maximum of 150 days, with an option to extend the measures past 150 days only by an Act of Congress.
The administration justified invoking Section 122 based on what it characterized as fundamental international payments imbalances: a $1.2 trillion annual goods trade deficit, a negative balance on primary income, and a net international investment position of negative 90% of GDP at the end of 2024. The proclamation set a 10% universal tariff, effective February 24, 2026, set to expire July 24, 2026.
The Courts Strike Again
The Section 122 gambit did not survive judicial scrutiny for long either. On the afternoon of May 7, 2026, the U.S. Court of International Trade issued a significant decision invalidating the Trump administration’s 10% global tariff imposed under Section 122.
The core legal problem is a conceptual one rooted directly in the post-Nixon monetary era. Section 122 allows the president to impose tariffs in response to “large and serious United States balance-of-payments deficits.” The Trump administration conflated balance-of-payments deficits with trade deficits to justify the tariffs. The United States does not, and cannot, while maintaining floating exchange rates, have a balance-of-payments deficit.
As legal analysts note, the term “balance-of-payments deficit” referred to a drawdown on official gold and other currency reserves under the old Bretton Woods currency peg system, which was abandoned in the early 1970s and officially terminated in 1976. Congress did not intend for Section 122 to apply to trade deficits when it passed the Trade Act of 1974.
In other words, the very statute that was created in response to the Nixon Shock may be legally inapplicable in a world where the Nixon Shock’s monetary consequences have become permanent. The administration is expected to appeal, and the Court’s ruling does not mean that the tariffs are entirely dead; relief was issued only for the specific plaintiffs, and the duties could last until July, when the administration is expected to unveil a backup plan using a different section of the same half-century-old legislation.
As of this writing, Trump is now 0-5 in judicial rulings on his trade war.
Section 301: The Administration’s Next Move
With Section 122 facing the courts, the administration has been simultaneously building its next legal architecture. At a press conference on February 20, 2026, President Trump indicated that the United States would launch investigations under Section 301 of the Trade Act of 1974 as a tool to replace the invalidated IEEPA tariffs. The Office of the U.S. Trade Representative subsequently outlined the targets: “industrial excess capacity, forced labor, pharmaceutical pricing practices, discrimination against U.S. technology companies and digital goods and services, digital services taxes, ocean pollution, and practices related to the trade in seafood, rice, and other products.”
Section 301 investigations are more procedurally burdensome than IEEPA or Section 122 tariffs. Section 301 actions are tied to investigations by the Office of the U.S. Trade Representative into foreign trade practices and typically involve public notices, opportunities for comment, and a developed administrative record supporting any eventual trade action. That means they take time. Treasury Secretary Bessent has stated that combining Section 122, Section 232, and Section 301 tariffs “will result in virtually unchanged tariff revenue in 2026,” signaling the administration’s resolve to find alternative avenues to reimpose the same levels of duties that were in place under IEEPA.
The Federal Reserve: Regulatory Oversight Tightens
The trade war is not the only front where executive financial authority has been tested. Early in 2025, Trump signed an executive order extending White House oversight to independent regulatory agencies, including the Federal Reserve. The scope and the carve-outs of that order have generated significant legal and institutional debate.
The scope of the order is broad, affecting all independent regulatory agencies. The only exemption is for “the Board of Governors of the Federal Reserve System or to the Federal Open Market Committee in its conduct of monetary policy.” The order does apply to the Fed “in connection with its conduct and authorities directly related to its supervision and regulation of financial institutions.”
The practical implication: the White House asserts authority over how the Fed regulates banks, but not over interest rate decisions. According to a senior administration official, the Office of Management and Budget will oversee all the Fed’s regulations not related to monetary policy.
Legal scholars have warned this distinction is difficult to maintain in practice. The Fed’s independence is a response to negative outcomes when the line between monetary policy and politics has been crossed. In the 1970s, President Nixon pressured the Fed to ease monetary policy in the run-up to his reelection, a move that contributed to spiking inflation that became entrenched.
On January 9, 2026, the Department of Justice served the Fed with subpoenas threatening a criminal indictment related to Chair Powell’s testimony before the Senate Banking Committee in June 2025 on the topic of building renovations. Jerome Powell is also due to be replaced as Fed chair in 2026. Some observers are concerned that Trump intends to select a chair who will not act independently. Treasury Secretary Scott Bessent has announced a shortlist of candidates that includes Fed Governors Christopher Waller and Michelle Bowman, National Economic Council Director Kevin Hassett, former Fed Governor Kevin Warsh, and BlackRock executive Rick Rieder.
The Gold Question: $42 an Ounce on the Government’s Books
Underneath the tariff and monetary battles runs a quieter but consequential thread: the valuation of U.S. gold reserves. The Treasury Department currently prices its gold holdings at $42 per ounce, a level set by law that has not changed since 1973. This figure is not a typo. It is the statutory relic of the Nixon Shock – the price at which the government froze gold’s book value when it severed the dollar’s convertibility.
The U.S. government still officially values its gold at just $42.22 per ounce. With total U.S. gold reserves at 261.5 million ounces, a full revaluation at market prices would unlock over $750 billion in financial value, according to analysts. At the end of January 2026, with gold trading at around $5,000 per ounce, the accounting value of approximately $11 billion had a market value of some $1.3 trillion.
President Trump announced his administration would audit U.S. gold reserves at Fort Knox in Kentucky. “We’re going to go to Fort Knox, the fabled Fort Knox, to make sure the gold is there,” Trump said. The audit campaign faded. Treasury Secretary Scott Bessent gave public assurances that “all the gold is present and accounted for,” and Trump and Elon Musk suddenly stopped talking about it.
Trump could use the Treasury’s Exchange Stabilization Fund, authorized under Title 31, Section 5302(b) of the U.S. Code, to buy and sell gold, potentially stabilizing the dollar in relation to a gold benchmark. While a full, legally binding gold standard would require Congressional approval, Trump could set a “gold target” for the dollar, creating a soft link to gold without committing to a formal gold standard.
No such action has been taken. But the conversation itself – about revaluing gold, auditing reserves, and connecting the dollar to a commodity anchor – echoes 1971 in ways that serious monetary analysts are not dismissing.
Most-Favored-Nation Drug Pricing: Executive Power Over Pharma
A separate but equally ambitious executive action concerns pharmaceutical pricing. On May 12, 2025, President Trump signed an executive order titled “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients,” directing the administration to take numerous actions to bring American drug prices in line with those paid by similar nations.
Under most-favored-nation pricing, Americans would pay no more for prescription drugs than the lowest prices for which those drugs are sold in other developed countries. To implement this, the order directs the U.S. Trade Representative and Secretary of Commerce to take steps against foreign nations that the administration believes to be suppressing drug prices abroad in ways that unfairly shift higher costs onto American consumers.
The administration claims significant early results. To date, the administration has reached voluntary MFN pricing agreements with 17 of the largest pharmaceutical manufacturers in the world. Moving forward, it expects to reach similar agreements with most manufacturers of sole-source brand name drugs and biologics. In parallel, the administration is working with Congress to codify those voluntary agreements into law.
The White House estimates the voluntary MFN framework requires manufacturers to make existing drugs available to state Medicaid programs at MFN prices, which would generate $64.3 billion in federal and state savings over the next 10 years.
Industry opposition is fierce. Shortly after the original order was signed, the Pharmaceutical Research and Manufacturers of America redirected attention to pharmacy benefit managers, insurers, and hospitals as the reason prices are high in the U.S., with CEO Stephen J. Ubl saying “importing foreign prices from socialist countries would be a bad deal for American patients and workers.”
An April 2026 executive order has since linked tariff relief and other benefits to manufacturers’ willingness to enter into MFN pricing and domestic production agreements, while establishing significant tariffs on companies that decline to do so. Critics contend this “re-share and re-price or pay” structure creates coercive conditions that may themselves face legal challenge.
Read More: Inside Trump’s Most Debated Executive Orders of 2025
Key Takeaways From a Record-Breaking Year of Executive Action
The 2026 financial and trade executive actions represent one of the most sustained attempts since the Nixon era to reshape the U.S. economic order through presidential proclamation alone. Several conclusions emerge clearly from the record.
First, the courts are functioning as a genuine check. The U.S. average effective tariff rate climbed to nearly 17% under IEEPA, the highest since the early 1930s. Research from the Federal Reserve Bank of New York found that nearly 90% of those costs were borne by American firms and consumers. The Tax Foundation estimated tariffs added about $1,000 to household costs in 2025 and as much as $1,300 in 2026. The Supreme Court’s ruling in Learning Resources v. Trump restored a constitutional principle – that tariff authority belongs to Congress – that had been eroded by decades of legislative delegation. Every business importing goods into the United States should monitor the Section 301 investigation schedule closely; those investigations are the administration’s most durable remaining tariff pathway.
Second, the Nixon Shock parallel is instructive but imperfect. Nixon’s actions in 1971 permanently changed the monetary order. The Trump administration’s ambitions are equally large, but the legal environment is far more contested, and the judiciary has moved quickly. The administration’s own legal arguments in court acknowledged that Section 122 was designed for a gold-standard-era balance-of-payments problem that no longer exists in a floating-currency world – a contradiction that has now cost it in federal court.
Third, the Fed independence question is unresolved and consequential. The selection of a new Federal Reserve chair in 2026 will be as financially significant as any executive order signed this year. A chair who subordinates monetary policy to political goals risks repeating the inflationary cycle of the late 1970s that required interest rates above 20% to correct.
What This Means for You
For anyone who pays taxes, buys imported goods, takes prescription medication, or holds savings in U.S. dollars, the events of 2026 are not abstract. The tariff battles of the past year have already added hundreds of dollars to the annual cost of goods for the average household, and the refund process for the $160 billion-plus in now-illegal IEEPA duties collected from American importers remains uncertain and unresolved. If you run a business that sources goods internationally, tracking the Section 301 investigation timeline is the single most important trade compliance task of the next six months. Those investigations are on an expedited schedule, with hearings already completed, and tariffs from that process could land before July 2026 – the same month the Section 122 tariffs are set to expire.
The common thread through these shocks – from Nixon’s gold exit to Trump’s tariff strategy – is that U.S. economic policy, whether by accident or design, tends to trigger global realignments. Whether the current realignment produces durable reform or a prolonged period of legal and economic instability depends on whether Congress, the courts, and the executive branch can find a framework that holds. For consumers and businesses alike, the practical advice is the same: assume the trade landscape will continue to shift through the end of the year, plan your finances and supply chains with flexibility in mind, and watch the appellate courts. In 2026, they are doing a job Congress has not yet chosen to do for itself.
AI Disclaimer: This article was created with the assistance of AI tools and reviewed by a human editor.
Read More: Trump’s Financial Disclosures Are Out — and Analysts Are Crying Foul